UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007131
Receipt number R000008391
Scientific Title Safety and efficacy of Fully-covered WallFlex stent in patients with distal malignant biliary obstruction: a prospective multicenter study
Date of disclosure of the study information 2012/01/24
Last modified on 2013/07/24 10:40:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of Fully-covered WallFlex stent in patients with distal malignant biliary obstruction: a prospective multicenter study

Acronym

WATCH-2 study

Scientific Title

Safety and efficacy of Fully-covered WallFlex stent in patients with distal malignant biliary obstruction: a prospective multicenter study

Scientific Title:Acronym

WATCH-2 study

Region

Japan


Condition

Condition

Malignant biliary obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the patency and safety of Fully-covered WallFlex stent for unresectable distal malignant biliary obstruction.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Stent patency period

Key secondary outcomes

Time to dysfunction, Stent occlusion rate, Stent-related complication rate, Overall survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Fully-covered WallFlex stent

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with unresectable distal malignant biliary obstruction, not limited to primary disease.
2) Patients with predictable prognosis of more than 2 months.
3) Patients with written informed consent.
4) Patients with performance status 0-2.

Key exclusion criteria

1) Patients with massive ascites.
2) Patients with severely impaired organ function.
3) Patients for whom endoscopic biliary drainage is difficult.
4) Patients with duodenal obstruction.
5) Patients considered ineligible for this study.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shomei Ryozawa

Organization

Showa University Northern Yokohama Hospital

Division name

Digestive Disease Center

Zip code


Address

35-1, Chigasaki-Chuo, Tsuzuki-ku, Yokohama

TEL

045-949-7000

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hirofumi Kogure

Organization

Faculty of Medicine, The University of Tokyo

Division name

Department of Gastroenterology

Zip code


Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Homepage URL


Email



Sponsor or person

Institute

Faculty of Medicine, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Faculty of Medicine, The University of Tokyo

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 01 Month 24 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 06 Month 09 Day

Date of IRB


Anticipated trial start date

2011 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 01 Month 24 Day

Last modified on

2013 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008391


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name